• A Corrigendum to this article was published on 20 September 2016

This article has been updated


The effect of alterations in intestinal microbiota on microbial metabolites and on disease processes such as graft-versus-host disease (GVHD) is not known. Here we carried out an unbiased analysis to identify previously unidentified alterations in gastrointestinal microbiota–derived short-chain fatty acids (SCFAs) after allogeneic bone marrow transplant (allo-BMT). Alterations in the amount of only one SCFA, butyrate, were observed only in the intestinal tissue. The reduced butyrate in CD326+ intestinal epithelial cells (IECs) after allo-BMT resulted in decreased histone acetylation, which was restored after local administration of exogenous butyrate. Butyrate restoration improved IEC junctional integrity, decreased apoptosis and mitigated GVHD. Furthermore, alteration of the indigenous microbiota with 17 rationally selected strains of high butyrate–producing Clostridia also decreased GVHD. These data demonstrate a heretofore unrecognized role of microbial metabolites and suggest that local and specific alteration of microbial metabolites has direct salutary effects on GVHD target tissues and can mitigate disease severity.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Change history

  • 26 August 2016

    In the version of this article initially published, the middle initial (C) for the sixteenth author was incorrect. The correct author name should be Thomas M. Schmidt (and the corresponding initials in the Author Contributions section should be T.M.S.). The error has been corrected in the HTML and PDF versions of the article.


  1. 1.

    et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559–563 (2014).

  2. 2.

    et al. A core gut microbiome in obese and lean twins. Nature 457, 480–484 (2009).

  3. 3.

    & The microbiome and graft versus host disease. Current Stem Cell Reports 1, 39–47 (2015).

  4. 4.

    et al. Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. J. Exp. Med. 209, 903–911 (2012).

  5. 5.

    et al. Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of α-defensins. Blood 120, 223–231 (2012).

  6. 6.

    & Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer. Nat. Rev. Cancer 10, 213–221 (2010).

  7. 7.

    & Graft-versus-host disease. Panminerva Med. 52, 111–124 (2010).

  8. 8.

    , , & Graft-versus-host disease. Lancet 373, 1550–1561 (2009).

  9. 9.

    et al. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood 124, 1174–1182 (2014).

  10. 10.

    , , , & Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host. Curr. Opin. Pharmacol. 13, 869–874 (2013).

  11. 11.

    & Digestion and absorption of fiber carbohydrate in the colon. Am. J. Gastroenterol. 81, 507–511 (1986).

  12. 12.

    & The effect of sodium butyrate on histone modification. Cell 14, 115–121 (1978).

  13. 13.

    & Review article: short chain fatty acids in health and disease. Aliment. Pharmacol. Ther. 12, 499–507 (1998).

  14. 14.

    et al. Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect. Proc. Natl. Acad. Sci. USA 101, 3921–3926 (2004).

  15. 15.

    et al. Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice. J. Clin. Invest. 118, 2562–2573 (2008).

  16. 16.

    et al. Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial. Lancet Oncol. 15, 87–95 (2014).

  17. 17.

    et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500, 232–236 (2013).

  18. 18.

    & The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood 95, 2754–2759 (2000).

  19. 19.

    et al. Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms. Exp. Hematol. 41, 261–270 (2013).

  20. 20.

    & Transcriptional control of cancer metastasis. Trends Cell Biol. 23, 603–611 (2013).

  21. 21.

    et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504, 446–450 (2013).

  22. 22.

    , & Nonionic diffusion of short-chain fatty acids across rat colon. Am. J. Physiol. 274, G518–G524 (1998).

  23. 23.

    et al. Cutting edge: negative regulation of dendritic cells through acetylation of the nonhistone protein STAT-3. J. Immunol. 182, 5899–5903 (2009).

  24. 24.

    et al. Increased intestinal permeability and tight junction disruption by altered expression and localization of occludin in a murine graft versus host disease model. BMC Gastroenterol. 11, 109 (2011).

  25. 25.

    et al. Increased tight junctional permeability is associated with the development of colon cancer. Carcinogenesis 20, 1425–1431 (1999).

  26. 26.

    Regulation of intestinal epithelial permeability by tight junctions. Cell. Mol. Life Sci. 70, 631–659 (2013).

  27. 27.

    et al. Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease. Immunity 37, 339–350 (2012).

  28. 28.

    et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504, 451–455 (2013).

  29. 29.

    , , & The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc. Natl. Acad. Sci. USA 111, 2247–2252 (2014).

  30. 30.

    et al. Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J. Exp. Med. 204, 57–63 (2007).

  31. 31.

    & In vivo depletion of FoxP3+ Tregs using the DEREG mouse model. Methods Mol. Biol. 707, 157–172 (2011).

  32. 32.

    & Mitosis and apoptosis: how is the balance set? Curr. Opin. Cell Biol. 25, 780–785 (2013).

  33. 33.

    , , , & Colonic health: fermentation and short chain fatty acids. J. Clin. Gastroenterol. 40, 235–243 (2006).

  34. 34.

    et al. Characterization of the 17 strains of regulatory T cell-inducing human-derived Clostridia. Gut Microbes 5, 333–339 (2014).

  35. 35.

    et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol. 75, 7537–7541 (2009).

  36. 36.

    , & Reducing the effects of PCR amplification and sequencing artifacts on 16S rRNA-based studies. PLoS ONE 6, e27310 (2011).

  37. 37.

    et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl. Environ. Microbiol. 72, 5069–5072 (2006).

  38. 38.

    , , , & Colonic gene expression in conventional and germ-free mice with a focus on the butyrate receptor GPR109A and the butyrate transporter SLC5A8. J. Gastrointest. Surg. 14, 449–461 (2010).

  39. 39.

    et al. The Wnt agonist R-spondin1 regulates systemic graft-versus-host disease by protecting intestinal stem cells. J. Exp. Med. 208, 285–294 (2011).

  40. 40.

    , , , & Treatment with a rho kinase inhibitor improves survival from graft-versus-host disease in mice after MHC-haploidentical hematopoietic cell transplantation. Biol. Blood Marrow Transplant. 20, 1104–1111 (2014).

  41. 41.

    & Isolation of Mouse Small Intestinal Intraepithelial Lymphocytes, Peyer's Patch, and Lamina Propria Cells (John Wiley & Sons, 2001).

  42. 42.

    et al. A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses. Nat. Med. 11, 1244–1249 (2005).

  43. 43.

    , , , & Altered metabolic profile with sodium-restricted dietary approaches to stop hypertension diet in hypertensive heart failure with preserved ejection fraction. J. Card. Fail. 21, 963–967 (2015).

  44. 44.

    et al. Evidence for a link between gut microbiota and hypertension in the Dahl rat. Physiol. Genomics 47, 187–197 (2015).

  45. 45.

    et al. Dynamics and establishment of Clostridium difficile infection in the murine gastrointestinal tract. Infect. Immun. 83, 934–941 (2015).

  46. 46.

    et al. The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res. 37, D141–D145 (2009).

  47. 47.

    , , & Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 73, 5261–5267 (2007).

Download references


This work was supported by the US National Institutes of Health (NIH) (National Heart, Lung and Blood Institute, grants HL-090775 and HL-128046 (to P.R.); National Cancer Institute, grant CA-173878 (to P.R.)). Metabolomic studies were performed through the Molecular Phenotyping Core, Michigan Nutrition and Obesity Center (grant DK089503 (to S.P.)) and Michigan Regional Metabolomics Resource Core (grant DK097153 (to S.P.)). We acknowledge use of the Microscopy & Image-analysis Laboratory (MIL) of the University of Michigan's Biomedical Research Core Facilities for preparation of samples and images. Support for the MIL core is provided by the University of Michigan Cancer Center (NIH grant CA46592) and the University of Michigan Gut Peptide Research Center (NIH grant DK34933).

Author information

Author notes

    • Nathan D Mathewson
    • , Robert Jenq
    • , Anna V Mathew
    • , Mark Koenigsknecht
    • , Alan Hanash
    • , Vincent B Young
    • , Subramaniam Pennathur
    •  & Marcel van den Brink

    These authors contributed equally to this work.


  1. Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA.

    • Nathan D Mathewson
    • , Tomomi Toubai
    • , Katherine Oravecz-Wilson
    • , Shin-Rong Wu
    • , Yaping Sun
    • , Corinne Rossi
    • , Hideaki Fujiwara
    •  & Pavan Reddy
  2. Graduate Program in Immunology, University of Michigan Medical School, Ann Arbor, Michigan, USA.

    • Nathan D Mathewson
    •  & Shin-Rong Wu
  3. Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

    • Robert Jenq
    • , Alan Hanash
    • , Yusuke Shono
    • , Caroline Lindemans
    • , Marco Calafiore
    •  & Marcel van den Brink
  4. Division of Nephrology, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, USA.

    • Anna V Mathew
    • , Jaeman Byun
    •  & Subramaniam Pennathur
  5. Division of Infectious Disease, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, USA.

    • Mark Koenigsknecht
    • , Thomas M Schmidt
    •  & Vincent B Young
  6. RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.

    • Kenya Honda


  1. Search for Nathan D Mathewson in:

  2. Search for Robert Jenq in:

  3. Search for Anna V Mathew in:

  4. Search for Mark Koenigsknecht in:

  5. Search for Alan Hanash in:

  6. Search for Tomomi Toubai in:

  7. Search for Katherine Oravecz-Wilson in:

  8. Search for Shin-Rong Wu in:

  9. Search for Yaping Sun in:

  10. Search for Corinne Rossi in:

  11. Search for Hideaki Fujiwara in:

  12. Search for Jaeman Byun in:

  13. Search for Yusuke Shono in:

  14. Search for Caroline Lindemans in:

  15. Search for Marco Calafiore in:

  16. Search for Thomas M Schmidt in:

  17. Search for Kenya Honda in:

  18. Search for Vincent B Young in:

  19. Search for Subramaniam Pennathur in:

  20. Search for Marcel van den Brink in:

  21. Search for Pavan Reddy in:


N.D.M. designed experiments, performed experiments, analyzed data and wrote the paper. A.V.M. and M.K. performed experiments and analyzed data. R.J. and A.H. designed and performed experiments. T.T., K.O.-W., S.-R.W., Y.S., C.R., H.F., J.B., Y.S., C.L. and M.C. performed experiments. T.M.S., V.B.Y. and M.v.d.B. wrote the paper. K.H. provided reagents and wrote the paper. S.P. analyzed data and wrote the paper. P.R. designed experiments, analyzed data and wrote the paper.

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Pavan Reddy.

Integrated supplementary information

Supplementary information

PDF files

  1. 1.

    Supplementary Text and Figures

    Supplementary Figures 1–6 and Supplementary Table 2

Excel files

  1. 1.

    Supplementary Table 1: qPCR primers

    Primers used with gene names indicated.

About this article

Publication history






Further reading Further reading